The Bruton's Tyrosine Kinase (BTK) Inhibitor ONO-4059: Promising Single Agent Activity and Well Tolerated in Patients with High Risk Chronic Lymphocytic Leukaemia (CLL)

被引：9

作者：

Fegan, Christopher ^{[1
]}

Bagshawe, Joanne ^{[1
]}

Salles, Gilles ^{[2
]}

Karlin, Lionel ^{[2
]}

Rule, Simon ^{[3
]}

Shah, Nimish ^{[3
]}

Morschhauser, Franck ^{[4
]}

Terriou, Louis ^{[4
]}

Dyer, Martin J. S. ^{[5
]}

Walter, Harriet ^{[5
]}

Hutchinson, Claire ^{[5
]}

Cartron, Guillaume ^{[6
]}

Sharpe, John ^{[7
]}

Duffy, Kevin ^{[7
]}

Nishimura, Akhisa ^{[7
]}

Abe, Shin-ichiro ^{[7
]}

Honda, Hideyuki ^{[8
]}

Yasuhiro, Tomoko ^{[8
]}

Yoshizawa, Toshio ^{[8
]}

Birkett, Joseph ^{[7
]}

Courtenay-Luck, Nigel ^{[7
]}

机构：

[1] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales

[2] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France

[3] Derriford Hosp, Plymouth PL6 8DH, Devon, England

[4] Hop Claude Huriez, CHRU, Lille, France

[5] Univ Leicester, Leicester, Leics, England

[6] CHU St Eloi, Montpellier, France

[7] ONO Pharma UK LTD, London, England

[8] Ono Pharmaceut Co Ltd, Osaka, Japan

来源：

关键词：

D O I：

10.1182/blood.V124.21.3328.3328

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3